The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Verbovskiy A.N.

Inozemtsev Municipal Clinical Hospital of Moscow Department of Health, Moscow, Russia

Pirogov S.S.

P.A. Gertsen Moscow Research Oncological Institute affiliated with the National Medical Research Centre of Radiology, Ministry of Health of the Russia, Russia

Bogdanov S.N.

Military medical unit, Golytsino, Moscow region, Russia, P.A. Gertsen Moscow scientific and research oncologic institute, National medical research center of radiology trust, Moscow, Russia

Ovchinnikov A.V.

Military medical unit, Golytsino, Moscow region, Russia

Sokolov V.V.

Military medical unit, Golytsino, Moscow region, Russia, P.A. Gertsen Moscow scientific and research oncologic institute, National medical research center of radiology trust, Moscow, Russia

Khomyakov V.M.

Military medical unit, Golytsino, Moscow region, Russia, P.A. Gertsen Moscow scientific and research oncologic institute, National medical research center of radiology trust, Moscow, Russia

Possibilities of endoscopy in the diagnosis and treatment of III type neuroendocrine tumors of the stomach

Authors:

Verbovskiy A.N., Pirogov S.S., Bogdanov S.N., Ovchinnikov A.V., Sokolov V.V., Khomyakov V.M.

More about the authors

Journal: Endoscopic Surgery. 2018;24(2): 51‑55

Read: 3120 times


To cite this article:

Verbovskiy AN, Pirogov SS, Bogdanov SN, Ovchinnikov AV, Sokolov VV, Khomyakov VM. Possibilities of endoscopy in the diagnosis and treatment of III type neuroendocrine tumors of the stomach. Endoscopic Surgery. 2018;24(2):51‑55. (In Russ.)
https://doi.org/10.17116/endoskop201824251

Recommended articles:
Diagnosis and treatment of three synchronous early squamous cell carcinomas of the esophagus: case report. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):104-110

References:

  1. Boyce M, Thomsen L. Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scand J Gastroenterol. 2015;50:550-559.
  2. Yuichi Sato, Satoru Hashimoto, Kenichi Mizuno, Manabu Takeuchi, Shuji Terai. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol. 2016 Aug 14;22(30): 6817-6828. Published online 2016 Aug 14. https://doi.org/10.3748/wjg.v22.i30.6817
  3. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E, Rindi G. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993 Apr;104(4):994-1006.
  4. Kovalenko TV, Budzinskii AA, Mel’chenko DS. Kartsinoid zheludka — sovremennye podkhody k diagnostike i lecheniyu. Eksperimental’naya i klinicheskaya gastroenterologiya. 2011;10:95-102. (In Russ.)
  5. Delle Fave G, Kwekkeboom DK, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, Sasano H, Tomassetti P, Salazar R, Ruszniewski P. ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95:74-87. https://doi.org/10.1159/000335595
  6. Khomyakov VM, Pirogov SS, Ivanov AS. Neiroendokrinnye opukholi zheludka: klassifikatsiya, diagnostika, lechenie (obzor literatury). Farmateka. 2016;17:75-81. (In Russ.)
  7. Jernman J, Välimäki MJ, Louhimo J, Haglund C, Arola J. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours. Neuroendocrinology. 2012;95(4):317-324. Epub 2012 Feb 7. https://doi.org/10.1159/000333035
  8. Crosby DA, Donohoe CL, Fitzgerald L, Muldoon C, Hayes B, O’Toole D, Reynolds JV. Gastric neuroendocrine tumours. Dig Surg. 2012;29:331-348.
  9. Sato Y. Endoscopic diagnosis and management of type I neuroendocrine tumors. World J Gastrointest Endosc. 2015;7:346-353.
  10. Perfil’ev IB, Delektorskaya VV, Kuvshinov YuP, Malikhova OA, Poddubnyi BK, Ungiadze GV, Pirogov SS. Sovremennye aspekty endoskopicheskoi semiotiki neiroendokrinnykh opukholei zheludka. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2011;21(4):27-36. (In Russ.)
  11. Yao JC, Hassan M, Phan A, et al. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008; 26(18):3063-3072.
  12. Scherübl H, Cadiot G, Jensen RT, Rösch T, Stölzel U, Klöppel G. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy. 2010;42:664-671.
  13. Jung JH, Choi KD, Koh YW, et al. Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level. Hepatogastroenterology. 2015 Jan-Feb;62(137):207-213.
  14. NCCN. The NCCN Gastric Cancer Clinical Practice Guidelines in Oncology (Version 1.2015) National Comprehensive Cancer Network (NCCN); 2015.
  15. Kwon KH, Jeon SW, Kim GH, et al. Long-term follow up of endoscopic resection for type 3 gastric NET. World J Gastroenterol. 2013 Dec 14;19(46):8703-8708. https://doi.org/10.3748/wjg.v19.i46.8703

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.